NFE2L2 and rectal cancer: In this study, we investigated the effects of downregulating and overactivating NRF2 on both chemo- and radio-resistance in colorectal cancer models in vitro, identified the key cellular pathways involved, and assessed the clinical relevance of NRF2 pathway activation in a large clinical rectal cancer dataset.